News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Exelgen Announces Partnerships with Two Leading European Biotechnology Companies


12/27/2007 9:55:03 AM

RICHMOND, Va. & BUDE, England--(BUSINESS WIRE)--Exelgen Ltd. (formerly Tripos Discovery Research), a wholly owned subsidiary of Commonwealth Biotechnologies, Inc. (CBI) (NASDAQ Capital Market: CBTE) and a leading provider of drug discovery chemistry services and small molecule products, today announced significant new collaborations with two prominent European-based Biotechnology companies. Because of the proprietary nature of the collaborations both companies have declined to be identified or disclose the contract values at this time. One company is a long standing client, the other a new client.

Read at BioSpace.com


comments powered by Disqus
Exelgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES